DirectoryMix Web Resources » Article Details

Trial Shows Micardis - Read More

Date Added: September 01, 2008 09:44:04 PM
The results of the TRANSCEND® trial demonstrate that Micardis® 80mg (telmisartan) reduces the risk of cardiovascular death, myocardial infarction/heart attack and stroke in high-risk cardiovascular patients by 13% compared with those patients already receiving best standard of care (p=0.

Category: Society » Death


No comments are posted yet


 
Name:*
Email:*
Website:  (optional)
Comment:*
(html and bb codes are filtered and not allowed)

Do the math:*CAPTCHA - Do The Math
 

Related Articles

Nichols side makes case for death penalty opponents on jury

The effort to find a jury for Brian Nichols ended its eighth day Saturday with 57 potential jurors questioned and 24 qualified for the 100-member jury pool. At this rate, the pool should be completed by the last week of August.

Friends, family mourn death of Canadian soldier

Canadian soldiers in Afghanistan are mourning the loss of a comrade, Capt. Jonathan Sutherland Snyder, who died after tumbling down a well during a nighttime patrol.

EASTPOINTE: Death, mourning to be talk of the day at society's event

The East Detroit Historical Society is hoping for big attendance Saturday at an event on a topic that would appear to be a crowd killer. Death and mourning will the subject of the society's free presentation, "Crepe, Crinoline and Corpses," from 1 to 4

Jail death of man convicted of killing officer ruled a homicide

UPPER MARLBORO, Md. — The death of a 19-year-old found slumped in his cell a day after he was jailed on charges of running over and killing a police officer has been ruled a homicide, authorities said Monday.

Sun Hydraulics Announces Death of Robert E. Koski, Founder and Chairman Emeritus

It is with deepest regrets that Sun Hydraulics Corporation reports that the founder of Sun, Bob Koski, died on October 11, 2008, at his home in Sarasota. Bob was 79 at the time of his death.